Serna Bio
Genetic Medicine with Small Molecules
Ontario, United States · Founded 2021 · $500K raised
- Headquarters
- Ontario, California
- Employees
- 1–10
- Founded
- 2021
- Website
- serna.bio
- Total Funding
- $500K
- Last Round
- $500K SeedJan 2021
- Rounds
- 1
About
Serna Bio is developing small molecules to modulate RNA function, unlocking the potential to treat diseases driven by biology intractable by other modalities.
Summary
Serna Bio is a Biotech company based in Ontario, United States, founded in 2021. It has raised $500K in total across 1 round, most recently a $500K Seed round in Jan 2021. Investors include Y Combinator, Amino Collective and Lifeforce Capital.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2021
Investors
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/sernabio"><img src="https://indexed.vc/api/badge/company/sernabio" alt="Serna Bio on Indexed.vc" width="260" height="76" /></a>